Renuka Raman is an expert in Biochemistry at NewYork–Presbyterian Hospital (United States). Renuka Raman has authored 12 publications, the most recent in 2022. SLR score: 37 (community average: 125). How the SLR is computed.

LeadR Profile

Renuka Raman NewYork–Presbyterian Hospital United States
37 ScienceLeadR Reputation 37
Network Map

Biochemistry

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2016 - 2022

Source: PubMed

Weill Cornell Medicine

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 12

Citations

Citations: 405 1st author: 4 Last author: 0 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
The regulation of CD73 in non-small cell lung cancer.
PMID 35598361 — cells, lung, neoplasms, carcinoma, non-small-cell lung, organoids, lung neoplasms, small cell lung carcinoma, mutation
Eur J Cancer202224
Inhibition of FGF receptor blocks adaptive resistance to RET inhibition in CCDC6-RET-rearranged thyroid cancer.
PMID 35510953 — cells, thyroid neoplasms, aftercare, thyroid gland, receptors, fibroblast growth factor
J Exp Med202211
PPP6C, a serine-threonine phosphatase, regulates melanocyte differentiation and contributes to melanoma tumorigenesis through modulation of MITF activity.
PMID 35368039 — cells, genes, promoter regions, genetic, melanoma, melanocytes, cell line, threonine, phosphoric monoester hydrolases, carcinogenesis, serine, mutation, phosphoprotein phosphatases
Sci Rep202210
Exploiting mesothelin in thymic carcinoma as a drug delivery target for anetumab ravtansine.
PMID 34876673 — cells, growth, thymoma, pharmaceutical preparations, neoplasms, maytansine, heterografts
Br J Cancer20218
Histone 3 Methyltransferases Alter Melanoma Initiation and Progression Through Discrete Mechanisms.
PMID 35223844 — methyltransferases, melanoma, methionine, melanocytes, histones, histone methyltransferases, mutation, lysine
Front Cell Dev Biol20224

LeadR Networks

Main global connection map